{"id":"W2302335519","doi":"10.18433/j3j02p","title":"The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy","year":2016,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Evolocumab; Proprotein convertase; Alirocumab; Medicine; Kexin; Statin; Clinical trial; Hyperlipidemia; Pharmacology; Internal medicine; Lipoprotein; LDL receptor; Cholesterol; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004623062,0.0005499306,0.001087792,0.001995011,0.0003115034,0.001039337,0.0005008464,0.001028351,0.002114787],"category_scores_gemma":[0.0006977987,0.0001886073,0.0006033619,0.0014967,0.0003864452,0.00164057,0.000563742,0.002049942,0.0007520122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000432597,"about_ca_system_score_gemma":0.001091697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008711926,"about_ca_topic_score_gemma":0.002064472,"domain_scores_codex":[0.9997447,0.00004767156,0.00004475165,0.00003672593,0.0001054042,0.00002086262],"domain_scores_gemma":[0.999714,0.0001317366,0.00004950377,0.000006352104,0.00007269376,0.00002575315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008894045,0.00006628707,0.0003156556,0.02375786,0.0001580577,0.0004613666,0.0001624635,0.0002024647,0.001572734,0.00324652,0.03176797,0.9381998],"study_design_scores_gemma":[0.0000283652,0.0001445635,0.001404974,0.009426952,0.0002202625,0.005340916,0.0002453089,0.0001139857,0.0003273227,0.002266104,0.9804543,0.00002691257],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001569709,0.998387,0.00007611881,0.0006094923,0.0002690754,0.000002051295,0.000005319225,0.000004353573,0.0004896731],"genre_scores_gemma":[0.0007508383,0.9979656,0.0001521744,0.0004208316,0.0003729462,0.000002782424,0.00001078895,9.875821e-7,0.000323068],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002114787,"threshold_uncertainty_score":0.007074594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08932132076456119,"score_gpt":0.4385950861546546,"score_spread":0.3492737653900935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}